Navigation Links
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
Date:3/24/2008

ATLANTA, March 24 /PRNewswire/ -- After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAME(TM) (Fluocinolone Acetonide in Diabetic Macular Edema) Study can continue under the current protocol, without change. The trial is studying the use of Medidur FA for the treatment of diabetic macular edema (DME).

FAME is two, duplicate, double-masked, randomized, multi-center studies that are following 956 patients in the U.S., Canada, Europe and India for 36 months in support of a planned global registration filing, with safety and efficacy assessed after two years of follow-up. Enrollment for the FAME study was completed in October 2007.

"Alimera is pleased with the response from the DSMB that they have once again recommended that our investigative efforts around this treatment continue without change to the current protocol," said Alimera CEO Dan Myers. As of this latest DSMB review, we continue to be on track for regulatory submissions in early 2010."

Earlier this month, Alimera announced that it would be assuming a majority stake in the development of Medidur FA. Alimera is also working with Emory University on an exploratory treatment using the Medidur delivery system with an NADPH oxidase inhibitor for the treatment of dry age-related macular degeneration (AMD).

Medidur, a tiny, injectable insert, is being studied as a way to deliver fluocinolone acetonide, a corticosteroid, to the retina for up to three years as a treatment for diabetic macular edema (DME). Using a proprietary 25 gauge injector system, an eye care professional injects the Medidur insert into the vitreous through a minimally invasive procedure in an outpatient setting.

Currently, 7.5 percent of the U.S. population has diabetes. Over time, almost all diabetics will develop some form of dia
'/>"/>

SOURCE Alimera Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
4. Molnlycke Drives Home the Fight Against Staph and Other MRSA Infections
5. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
6. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
7. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
8. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
9. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
10. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
11. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repor...eport is available in its catalogue: ,, The Fu...o 2015, Competitive Benchmarking, Product Pipeline...r.com/p0166817/The-Future-of-Oncology-Therapeutics...ng-Product-Pipeline-and-Deals-Analysis.html ,,...
(Date:12/1/2009)... , Radiologist reports 90 percent radiation red...PRNewswire-USNewswire/ -- Dr. James Earls, a radio...burban Washington, D.C. will present the findings ...e amount of radiation heart patients received from...o. ,, Dr. Earls will present the study to the...
(Date:12/1/2009)... , CHERRY HILL, N.J., Dec. 1 /PRN...n Francis Bodine was surprised and delighted when ...ancer went from about 20 minutes each day to less ..., doctors at the Delaware Valley Urology Cancer C...; radiotherapy technology from Varian Medical Sys...
Breaking Medicine Technology:Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Spatial Integrated Systems Inc Files Patent Application 10210 1Spatial Integrated Systems Inc Files Patent Application 10210 2Wrist fracture patients less likely to be evaluated for osteoporosis 58645 1Wrist fracture patients less likely to be evaluated for osteoporosis 58645 2Blood diagnosis chip based and mobile 58640 1Blood diagnosis chip based and mobile 58640 2
(Date:12/1/2009)...velopment of simple screening test, expert says ,... a finding that could lead to a simple blood test ...dentified immune system markers that indicate earl...g cancer. , The researchers examined gene expre...ith non-small cell lung cancer and a control group...
(Date:12/1/2009)...would benefit from liver surgery after chemo, stud... News) -- A CT scan of liver tumors caused by the ...ll survival after chemotherapy, researchers report...hemotherapy has been shown to improve survival in ...produce better results in patients having surgery ...
(Date:12/1/2009)...n because pandemic,s course remains unpredictable ...A U.S. health official said Tuesday that H1N1 swin...ly, but many experts agreed the virus could return...idespread in 32 states -- down from 43 states the ...e U.S. Centers for Disease Control and Prevention ...
(Date:12/1/2009)..., 2009)The Clinical Research Building (CRB), at th...as been honored for its sustainability components....tablished by the U.S. Green Building Council and v...ute (GBCI). LEED is the nation,s preeminent progra...een buildings., "Having a LEED certified building...
(Date:12/1/2009)... Ever thought you could quit smoking while you,re ...roundbreaking new system for quitting is easy, pai...enty eight days your cravings and desire to smoke ... (PRWEB) December 1, 2009 -- Izabella had tried...iction to nicotine, smoking at least a pack a day....
Breaking Medicine News(10 mins):Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3
...achytherapy, intensity-modulated radiotherapy (IMR...dy radiotherapy (SBRT) , , PALO ALTO, Calif., Apr...showcase the company,s full spectrum of prostate c...n offers state-of-the-art technology for all five ...
...n goes undetected until rupture , , FRIDAY...at risk of an abdominal aortic aneurysm are gettin...An abdominal aortic aneurysm is a weak area in the...rtic aneurysms initially have no symptoms but can ...
...a erases the advantage, study finds, , , F... in the armed forces tend to be in better health t...xperienced combat duty, that initial health advant...ed Friday at the American Heart Association,s 10th...
...the role of prostaglandins a family of fatty comp...ressure maintenance, researchers at the University... discovered that mice that lack the receptor for o...ole for the type of prostaglandin studied, PG F2-a...
... and Mid-Sized Drug Companies to Adopt "Smart" Dru...O, Calif., April 24 /PRNewswire-FirstCall/ -- ... third party logistics provider Golden State Medic...tions in advance of state and federal mandates. ,...
...s to Medigap Secondary Insurance for Florida,s Mos...a., April 24 The Florida Legislature voted today ...l population of Florida,s kidney failure patients ...d for this legislation. , , Mourning, who is also...
Other Medicine News:Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 2Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 3Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 4Health News:Too Few Screened for Abdominal Aneurysm, Study Says 2Health News:Combat Duty Harms Long-Term Health of Vets 2Health News:Combat Duty Harms Long-Term Health of Vets 3Health News:New target for maintaining healthy blood pressure discovered 2Health News:New target for maintaining healthy blood pressure discovered 3Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 2Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 3Health News:Florida Legislature Renames Proposed Bill to Help State's Kidney Failure Patients "The Alonzo Mourning Access to Care Act" 2
CA-1000 (220V/50Hz)
...que DNA sequencing reagents including linear poly...istry and cyanine-based infrared dyes- coupled wit...ction, ore meaningful raw data, and higher-quality...0 to resolve complex sequences, filling in the gap...
ABL555 Blood gas analyzer
Rapidlink Critical Care Information Management System
Medicine Products: